BREAKING: Sesko fires Man. United past Everton in tense Premier League clash

Follow Us: Facebook Twitter Instagram YouTube
LATEST SCORES:
Loading live scores...
News

Naira policy: Healthcare in pathetic state

Plateau Govt assures on Anti-Snake Venom
FILE: Doctors attending to patients of snake bites in a health facility

Quick Read

“A patient that is critically sick and cannot access money to pay for drugs is a terrible combination."

Fatima Mohammed-Lawal

The Nigeria Medical Association (NMA) and Pharmaceutical Society of Nigeria (PSN) say the new naira policy has worsened the healthcare situation in the country as people find it difficult to access services and drugs due unavailability of cash.

The Kwara NMA Chairman, Dr Ola Ahmed, said this during an interview with newsmen in Ilorin, adding that some patients may die due to the unavailability of cash to pay for healthcare services in hospitals.

He said “patients are in a dire situation as they are unable to buy required drugs to stay alive.

“A patient that is critically sick and cannot access money to pay for drugs is a terrible combination.

“While the money transfer platforms are not easy to make as services tend not to work, some people use the opportunity to dupe others by sending fake transfer alerts,” he lamented.

Ahmed, however, said that the Kwara NMA would visit the management of the University of Ilorin Teaching Hospital (UITH) and the Kwara State Hospital Management Board to discuss how best to tackle the situation to save lives.

According to him, the association will also visit both government and private hospitals to find ways to tackle the situation.

On her part, Munirat Bello, the Secretary of the Kwara PSN, said pharmacists have been trying to be humanitarian in the face of the challenge by giving drugs on credit.

She added that “patients who received drugs on credit can refund when they are able to.

“But the risk is that some people don’t come back to pay. However, we will continue to engage with customers and patients to save lives.

Comments

×